Short answer
CME Group (CME) filed its Q1 2026 10-Q quarterly report on Apr 24, 2026 for the quarter ended Mar 31, 2026. Quarterly revenue was $1.9B (up 14.5% year over year) with net income of $1.2B.
Q1 2026 key financials · XBRL
- Revenue
- $1.9B
- +14.5% YoY
- Net income
- $1.2B
- +23.7% YoY
- Operating margin
- 69.7%
- EPS (diluted)
- $3.18
- +21.4% YoY
Source: XBRL data from the CME Group (CME) Q1 2026 10-Q on SEC EDGAR. USD.
CME Group Q1 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $1,880.1M, up 14% from $1,642.3M YoY
- Operating margin 69.7% vs 67.5%; net income $1,154.3M, up 21%
- Best product line metals volume 1,682K ADV, up 130%; worst foreign exchange up 4% to 1,193K
- Operating cash flow $1,259.9M, up 13% from $1,116.6M; cash $2.4B vs $4.4B at December 31, 2025
- Management cited Middle East conflict, supply disruptions, and market volatility as near-term headwinds driving higher volumes
Risk Factors
- No material changes to risk factors from the December 31, 2025 Form 10-K
- Carried-forward risks include regulatory changes affecting derivatives markets and clearing operations
- Carried-forward operational risk from technology failures disrupting trading, clearing, or settlement
- Carried-forward financial risk from market volatility affecting transaction volumes and clearinghouse exposures
- Share repurchase authorization up to $3.0 billion with $2,199.8 million remaining at March 31, 2026
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other CME Group quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.